Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-di hydro-3H`1,2,4!triazin-2-YL!-benzamide derivatives by deprotecting the hydroxyl-protected precursers

Details for Australian Patent Application No. 2005258911 (hide)

Owner Pfizer Products Inc.

Inventors Li, Zhengong, B.

Agent Shelston IP

Pub. Number AU-A-2005258911

PCT Pub. Number WO2006/003500

Priority 60/583,851 29.06.04 US

Filing date 16 June 2005

Wipo publication date 12 January 2006

International Classifications

C07D 253/075 (2006.01) Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2006/003500 Priority application(s): WO2006/003500

2 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005258912-Process for preparing synthetic intermediates useful in preparing pyrazole compounds

2005258906-Substituted heteroaryland phenylsulfamoyl compounds